论文信息 - 922 Adalimumab Maintains Long-Term Remission in Moderately to Severely Active Crohn's Disease Through 2 Years - 字舞流文

922 Adalimumab Maintains Long-Term Remission in Moderately to Severely Active Crohn's Disease Through 2 Years

P. Rutgeerts | G. D'Haens | W. Sandborn | R. Panaccione | R. Wong | J. Colombel | P. Pollack | Ju Li | K. Lomax